- About Us
- Nano-Social Network
- Nano Consulting
- My Account
|Photo / Donna Coveney
Tyler Jacks, Director of the David H. Koch Institute for Integrative Cancer Research, gave the introduction at the 2008 Koch Institute Symposium entitled Nanotechnology and Cancer: The Power of Small Science, held at Kresge Auditorium on Friday, June 24. Behind him are pixtures of faculty members who comprise the Koch Institute. Open image gallery
Speakers from MIT and other institutions described the promise of nanotechnology to help diagnose, treat and monitor cancer at the annual symposium hosted by the David H. Koch Institute for Integrative Cancer Research at MIT on Friday, June 27.
More than 1,100 people attended the symposium, titled "Nanotechnology and Cancer: The Power of Small Science."
Institute Professor Robert Langer, a pioneer in nanotechnology, described new techniques that researchers in his lab are using to create delivery systems for gene therapy and RNA interference. They have developed new ways to quickly synthesize a vast array of polymers that can be modified for optimal ability to deliver their payload, whether it's DNA, RNA or a drug.
"Small changes in chemistry can make huge changes in what you get," said Langer, who is also a member of the Koch Institute. "You can find very different properties and pick out polymers that do different things."
Langer and Sangeeta Bhatia, professor of electrical engineering and health sciences and technology and a member of the Koch Institute, talked about the prospect of building nanodevices that diagnose tumors, deliver drugs, and monitor the progress of treatment, all in one device.
Paula Hammond, the Bayer Professor of Chemical Engineering at MIT and Koch Institute member, described the polymers that her lab is developing to deliver cancer drugs directly to tumor cells. She uses self-assembling polymers with specific molecules attached that allow the nanoparticles to find and bind to tumor cells.
"We've been able to design these systems so they can act as very specific targeting vehicles for drug delivery," said Hammond.
Other speakers included Ralph Weissleder, director of the Center for Systems Biology at Massachusetts General Hospital, who described several types of nanoparticles his group is developing to detect cancer in its early stages. Weissleder and Langer are principal investigators of the MIT-Harvard Center of Cancer Nanotechnology Excellence.
This is the first cancer symposium held since the MIT Center for Cancer Research officially became the David H. Koch Institute for Integrative Cancer Research. The institute will be located in a new building now under construction at the corner of Main and Ames streets.
The institute will house both cancer biologists and engineers, who will work together to find new ways to detect, treat and prevent cancer.
"I'm convinced that the Koch Institute, in both the design of the building and its organization, will help define and accelerate a whole new era in cancer research," said MIT President Susan Hockfield, who opened Friday's symposium.
The mission of MIT is to advance knowledge and educate students in science, technology, and other areas of scholarship that will best serve the nation and the world in the 21st century.
For more information, please click here
MIT News Office
Copyright © MITIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
National Conference on Nanomaterials, (NCN-2017) April 21st, 2017
Nanomechanics, Inc. Unveils New Product at ICMCTF Show April 25th: Nanoindentation experts will launch the new Gemini that measures the interaction of two objects that are sliding across each other – not merely making contact April 21st, 2017
Forge Nano 2017: 1st Quarter Media Update April 20th, 2017